美国法院允许Sun Pharma在专利争议中发射LEQSELVI, 用于自发免疫障碍。 U.S. court allows Sun Pharma to launch LEQSELVI for autoimmune disorders amid patent dispute.

美国上诉法院已解除一项初步禁令,阻止Sun制药工业发射LEQSELVI,这是一种治疗某些自体免疫障碍的药物。 The U.S. Court of Appeals has lifted a preliminary injunction blocking Sun Pharmaceutical Industries from launching LEQSELVI, a drug for treating certain autoimmune disorders. 尽管Sun Pharma目前正在与Incyte Corporation提起专利侵权诉讼, Despite ongoing patent infringement litigation with Incyte Corporation, Sun Pharma can now proceed with the drug's launch, though detailed plans will be announced later.